Ledger.Open graph →
SEC Form D · filed October 3, 2023

ENB Therapeutics, Inc

Offering
$1.0M
Sold
$225K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Barbara Schilberg · New York, NYDirectorAlbert Sokol · New York, NYExecSumayah Jamal · New York, NYExec · DirectorBridget M. Cole · WALTHAM, MADirectorJoseph Strycharz · Charlotte, NCExec · DirectorStephen Buchanan · Charlotte, NCExecStuart Hwang · New York, NYDirectorWalter Olesiak · CAMBRIDGE, MADirectorJames Howes · Sydney NSW, Channel IslandsDirectorTejroop S. Sehmi · SANTA FE SPRINGS, CAExec · DirectorNavjot S. Sehmi · SANTA FE SPRINGS, CAExecStuart Hwang · New York, NYDirectorWalter Olesiak · CAMBRIDGE, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗